Sinem Namdaroglu - Publications

Encouraging response rates and high mobilization success with brentuximab vedotin plus GDP in adult relapsed/refractory classical Hodgkin lymphoma: A real-world study.

Journal: Leukemia research reports

Published: December 04, 2025

Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study.

Journal: Journal of clinical medicine

Published: October 26, 2025

Is there a relationship between stem cell yield obtained from healthy donors and healthy donors' blood type?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: July 08, 2025

Does body mass index affect stem cell yield in healthy donors?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: July 03, 2025

Analysis of peripheral stem cell mobilization research progress (2000-2023) based on bibliometric data.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: June 27, 2025

Fresh and cryopreserved stem cell transplantation in myeloma patients: Does it make a difference to transplant outcomes?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: June 26, 2025

The effect of threosulfan-based versus busulfan-based preparation regimens on transplant outcomes.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: June 24, 2025

The role of ruxolitinib in the management of acute GVHD.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: December 25, 2024

Are mesenchymal stem cells still effective in acute GvHD management?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: December 25, 2024

Is there a relationship between vitamin D levels and graft versus host disease?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: December 22, 2024

Efficacy of Ruxolitinib in the management of chronic GVHD.

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: December 21, 2024

What should be the optimal dose of post-transplantation cyclophosphamide for GVHD prophylaxis in allogeneic stem cell transplantation?

Journal: Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

Published: December 19, 2024